An interventional study of Behavioral: Exercise in Clinical Deterioration, sponsored by Fundacion Miguel Servet. Recruiting at 1 site in Spain. Open to participants aged 75 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-16.
Sponsored by Fundacion Miguel Servet · Not applicable, Interventional, and Prevention
The study is a randomized controlled trial conducted in the Geriatrics Department of a tertiary hospital in Spain (Hospital Universitario de Navarra). Participants aged 75 years or older will be recruited within the first 48 hours of admission to the acute care ward. Eligible hospitalized patients will be randomly assigned to either the intervention or control group using permuted block randomization (block sizes of 8 and 10), with consideration of gender balance.
Data will be collected at four time points: baseline assessment, hospital discharge, 1 month, and 3 months post-discharge.
Inclusion criteria include age ≥75 years and admission to the acute care unit. Exclusion criteria include refusal or inability to provide informed consent, life expectancy \<3 months or terminal illness (oncological or non-oncological), inability to complete follow-up, medical contraindications to exercise, severe neurocognitive impairment (GDS-FAST stage 7), or severe disability (Barthel Index \<35).
General Objective
To determine whether an intervention consisting of a multicomponent physical exercise program based on strength, balance, and aerobic training can prevent hospitalization-associated disability in adults aged 75 years and older admitted for acute medical conditions, while improving functional and cognitive capacity.
Specific Objectives
Exclusion Criteria:
Multicomponent individualized exercise intervention As mentioned earlier, patients in the control group (G0) will receive the usual care currently provided to other patients, which includes a referral to physical therapy if needed. The intervention for the multicomponent physical exercise intervention group (G1) will consist of a multicomponent physical training program that includes progressive and supervised aerobic endurance, strength, and balance training lasting 4-7 days during their hospitalization. This will be supervised by the research team from the Geriatrics Unit. Additionally, after hospital discharge, they will receive individualized guidelines to engage in multicomponent physical exercise for 3 months, along with individualized recommendations from the Nutrition and Dietetics Service of HUN. The multicomponent physical training program will consist of chair squat exercises. The main part of the training will utilize machines for strength training for the lower extremit
Other: Behavioral: Exercise
Multicomponent individualized exercise intervention As mentioned earlier, patients in the control group (G0) will receive the usual care currently provided to other patients, which includes a referral to physical therapy if needed. The intervention for the multicomponent physical exercise intervention group (G1) will consist of a multicomponent physical training program that includes progressive and supervised aerobic endurance, strength, and balance training lasting 4-7 days during their hospitalization. This will be supervised by the research team from the Geriatrics Unit. Additionally, after hospital discharge, they will receive individualized guidelines to engage in multicomponent physical exercise for 3 months, along with individualized recommendations from the Nutrition and Dietetics Service of HUN. The multicomponent physical training program will consist of chair squat exercises. The main part of the training will utilize machines for strength training for the lower extremit
Functional status
Short Performance Physical Battery (SPPB)
Time frame: Through study completion, an average of 3 months
Barthel Index
Basic activities of daily living
Time frame: Through study completion, an average of 3 months]
Mini-Mental State Examination (MMSE)
Cognition
Time frame: Through study completion, an average of 3 months
Trail Making Test A
Complex attention
Time frame: Through study completion, an average of 3 months
GDS Yesavage
Depression
Time frame: Through study completion, an average of 3 months
EuroQol-5D-3L
Quality of life
Time frame: Through study completion, an average of 3 months
Number of medications
Number of medications before and after de intervention
Time frame: Through study completion, an average of 3 months
Falls
Number of falls during the study
Time frame: Through study completion, an average of 3 months
Mortality
Mortality during the study
Time frame: Through study completion, an average of 3 months
Hospital Readmissions
Number of Hospital Readmissions
Time frame: Through study completion, an average of 3 months
Hand Grip
Maximum isometric strength
Time frame: Through study completion, an average of 3 months
Length of stay
Average length of hospital stay
Time frame: Through study completion, an average of 3 months
SATED scale
Changes in sleep quality
Time frame: Through study completion, an average of 3 months
Changes in plasma/serum proteomic profiles.
Protein expression profiles will be assessed to identify changes in circulating proteins associated with the intervention and to explore potential biological pathways involved in the observed effects
Time frame: Through study completion, an average of 3 months
Changes in DNA methylation profiles and epigenetic age
Buffy coat samples will be used for DNA extraction. Extracted DNA will be hybridized on DNA methylation arrays to assess genome-wide methylation profiles and identify differentially methylated regions/sites associated with the intervention. DNA methylation data will also be used to estimate biological age through established epigenetic clocks, allowing the evaluation of changes in epigenetic age and/or epigenetic age acceleration.
Time frame: Through study completion, an average of 3 months
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fundacion Miguel Servet